Start here if you're new
what it is
PetVivo makes animal health devices and therapies, led by a joint-treatment product for dogs and horses.
how it gets paid
Last year Petvivo made $1M in revenue.
why it's growing
Revenue grew 16.9% last year. $887K mattered most because it shows demand is moving.
what just happened
Revenue hit $887K last quarter, up 210% vs. prior year, while EPS was still negative.
At a glance
C++ balance sheet — some cracks in the foundation
50/100 earnings predictability — expect surprises
-$0.41 fy2024 eps (reported / est)
~$1M-scale revenue · still pre-profit
n/a operating margin — losses dwarf sales
xvary composite: 33/100 — weak
What they do
PetVivo makes animal health devices and therapies, led by a joint-treatment product for dogs and horses.
You have 18 products in the pipeline and 1 named lead product. That is a wide idea set versus a tiny sales base. The wall around it is not hype. It is 12 patents and 6 trade secrets, which means copying the formula is harder than copying the stock chart.
How they make money
$1M
annual revenue · their business grew +16.9% last year
total revenue
$1M
+16.9%
The products that matter
animal osteoarthritis therapy
SPRYNG Therapy
~$303K · SPRYNG in the latest quarter
Total company revenue in that quarter was ~$887K — this line is the named therapy slice inside it. If PETV works, SPRYNG is almost certainly why. If it does not, there is no second engine here to rescue the quarter.
core product
exclusive white-label pet technology deal
Digitallandia Partnership
10-year exclusive agreement
This is the main scale narrative in the current setup. A 10-year exclusive deal sounds large because, against $1.11M in trailing revenue, it has to.
growth bet
distribution channel
National Distributor Sales
$237K in the latest quarter
Within the disclosed SPRYNG-related mix for that period, this channel was ~78% — not 78% of total company sales (~$887K). Concentration simplifies the story; it also means one weak distributor shows up fast.
~78% of SPRYNG mix
Key numbers
$1M
annual revenue
This is the size of the whole business. You are not buying a giant. You are buying a $1M revenue base with a public ticker.
62.2%
gross margin
Gross margin → revenue after product cost → so what: the product itself keeps 62.2 cents before overhead eats it.
n/a
operating margin
Prior margin KPI failed sanity check — verify in filings. On a tiny revenue base, operating losses dominate — the margin ratio is deeply negative. Read it as structural burn, not operating leverage yet.
18
pipeline count
Pipeline count → number of products in development → so what: the company has more ideas than sales, which is both hope and risk.
Financial health
C++
strength
- balance sheet grade C++ — below average — limited financial resources
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market
Return history isn't available for PETV right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Revenue hit $887K last quarter, up 210% vs. prior year, while EPS was still negative.
The top line grew fast from a tiny base. The loss stayed ugly, but gross margin at 62.2% shows the product can still produce decent gross profit.
$887K
quarter revenue
-$0.27
eps
62.2%
gross margin
top line jump
$887K mattered most because it shows demand is moving, even if the company is still far from scale.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the risk is not abstract. PETV has to turn one therapy, ~$887K of quarterly company revenue (~$303K on the SPRYNG line), and ~62% gross margin into a real operating business before repeated equity raises do the job for it.
med
Commercial traction stays small for longer than the balance sheet can tolerate
The latest quarter produced ~$887K of total revenue (~$303K attributed to SPRYNG in disclosures). The same quarter produced a ~$3M net loss. That is a scale problem, not a gross-margin problem.
If sales stay in the low hundreds of thousands, the current $28M equity value has very little fundamental support.
med
Dilution keeps funding the gap between ambition and revenue
The March 13, 2026 equity financing raised $1M. Against a $28M market cap, that is roughly 3.6% of current value from one small raise.
If revenue does not inflect, you should expect more funding to come from new shares, which means your slice of the company keeps shrinking.
med
The scale narrative leans too hard on one long agreement
PETV's 10-year exclusive Digitallandia agreement is real, but it matters this much because trailing revenue is only $1.11M and the business lacks another proven growth engine.
If the partnership underdelivers, you are not losing a side bet. You are losing a large part of the reason investors pay up today.
$303K of quarterly revenue is being asked to support a business that lost $3M in the same quarter and just raised $1M of new equity. That is the risk picture in one sentence.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
Quarterly revenue climbing past ~$1M
The latest quarter was ~$887K company-wide (~$303K on SPRYNG). Until the total keeps stepping up, the rest of the story is setup, not proof.
calendar
Q4 2026 earnings release
Scheduled for Monday, August 17, 2026. You want revenue progress in dollars, not just another percentage headline from a tiny base.
trend
Gross margin holding near 62%
Gross margin was ~62.2%. If scale shows up and that level holds, the unit-economics case gets more believable — but operating costs still have to come down.
risk
Another equity raise before revenue inflects
The company already raised $1M in March 2026. If that pattern repeats before sales accelerate, dilution starts looking less like bridge financing and more like the business model.
Analyst rankings
earnings predictability
50 / 100
A middle score on a business this small means results swing around with a few orders. In human-speak, analysts do not have a stable earnings pattern to trust yet.
beta
0.9
Beta measures how a stock has moved relative to the market. A 0.9 beta sounds tame. The real volatility here is operational, not statistical.
source: institutional data
Institutional activity
institutional ownership data for PETV is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$0.92
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive